Keywords
World Health Organization
Global Health Governance
Infectious Disease Control
Health Cooperation
Categories
How to Cite
Abstract
As the core coordinating body for global health governance, the World Health Organization (WHO) now faces a structural turning point following the formal termination of cooperation by the United States. From a professional perspective, this paper analyzes the profound impact of the U.S. withdrawal across three core pillars: global pandemic surveillance systems, immunization programs and disease eradication initiatives, and the prevention and control of non-communicable diseases (NCDs) and antimicrobial resistance (AMR). It identifies governance risks such as surveillance fragmentation, standard divergence, and the loss of professional resources. Furthermore, aligned with global health development needs, this paper proposes new collaborative pathways—strengthening regional governance, deepening scientific research collaboration, optimizing public-private partnerships, and advancing digital infrastructure—to provide a framework for constructing a more resilient global health governance system.
References
[1] Gostin LO, Koh HH, Williams M, et al. US withdrawal from WHO is unlawful and threatens global and US health and security. Lancet. 2020;396(10247):293-295. doi:10.1016/S0140-6736(20)31527-0
[2] Aremu SO, Adamu AI, Obeta OK, et al. The United States withdrawal from the world health organization (WHO), its implications for global health governance. Global Health. 2025;21(1):48. Published 2025 Aug 12. doi:10.1186/s12992-025-01137-0
[3] Marcenac P, McCarron M, Davis W, et al. Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic. Emerg Infect Dis. 2022;28(13): S26-S33. doi:10.3201/eid2813.212248
[4] Mshelia SE, Blackmore C, Archer R, Booth A. Factors affecting the successful implementation of Global Polio Eradication Initiative (GPEI) in low- and middle-income countries. J Glob Health. 2020;10(1):010322. doi:10.7189/jogh.10.010322
[5] Mahoney R, Hotez PJ, Bottazzi ME. Global regulatory reforms to promote equitable vaccine access in the next pandemic. PLOS Glob Public Health. 2023;3(10): e0002482. Published 2023 Oct 18. doi:10.1371/journal.pgph.0002482
[6] Bertagnolio S, Dobreva Z, Centner CM, et al. WHO global research priorities for antimicrobial resistance in human health. Lancet Microbe. 2024;5(11):100902. doi:10.1016/S2666-5247(24)00134-4
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Frontiers in Preventive Medicine